Sponsored Article
Undone Proteins Take Out Bladder Cancer
Undone Proteins Take Out Bladder Cancer
Roni Dengler, PhD | Jul 20, 2021
An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer.
Homing Technology Delivers Therapy to Cancerous Bone
Homing Technology Delivers Therapy to Cancerous Bone
Roni Dengler, PhD | Jul 19, 2021
A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.
Antibiotic-Linked Antibody Attacks Cancer’s Sinister Neighbor Cells
Antibiotic-Linked Antibody Attacks Cancer’s Sinister Neighbor Cells
Roni Dengler, PhD | Jul 14, 2021
An unexpected and unprecedented finding may lead to improved cancer therapies.
Glucometers Detect SARS-CoV-2 Infection Within an Hour
Glucometers Detect SARS-CoV-2 Infection Within an Hour
Roni Dengler, PhD | Jun 14, 2021
Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Roni Dengler, PhD | Jun 14, 2021
Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.
Skin Rash May Point to SARS-CoV-2 Infection
Skin Rash May Point to SARS-CoV-2 Infection
Roni Dengler, PhD | Jun 14, 2021
Skin symptoms are often the first, or only, symptom of COVID-19.
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
Berly McCoy, PhD | May 25, 2021
Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.
Engineered Immune Cells Eliminate Brain Cancer in Mice
Engineered Immune Cells Eliminate Brain Cancer in Mice
Brooke Dulka, PhD | May 25, 2021
Researchers developed a new CAR T-cell therapy that targets specific growth factor receptors in glioblastoma to eliminate brain tumors.
Environmental Cues Keep CAR T Cells on Track
Environmental Cues Keep CAR T Cells on Track
Aparna Nathan | May 25, 2021
Pairing CARs with a synthetic receptor makes T cells more lethal tumor killers.
<strong>The Rise of Cannabis Extraction Labs</strong>
The Rise of Cannabis Extraction Labs
Chemyx Inc. | Nov 20, 2020
Scientists in cannabis extraction laboratories are bravely pioneering a new field of agro-chemical engineering.
The MSC: Regeneration Orchestrator
The MSC: Regeneration Orchestrator
| Nov 16, 2020
Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.
The Past, Present, and Future of Lab Balances
The Past, Present, and Future of Lab Balances
Sartorius | Nov 2, 2020
A conversation with Dirk Ahlbrecht from Sartorius about where lab balance technology is headed in the 21st century
Predicting and Overcoming Resistance Using IsoPlexis&#39; Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools
Predicting and Overcoming Resistance Using IsoPlexis' Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools
IsoPlexis | Sep 11, 2020
Cancer cells develop resistance to targeted therapies, and their inherent functional heterogeneity makes it difficult for researchers to understand and characterize these resistance mechanisms. IsoPlexis' single-cell proteomics is helping researchers overcome resistance to targeted inhibitors, leading to better strategies and combination therapies.
<strong>Combating COVID-19 with Cell-Free Expression</strong>
Combating COVID-19 with Cell-Free Expression
The Scientist Creative Services Team | Aug 19, 2020
Scientists rely on synthetic biology and cell-free expression systems for developing novel approaches to combat the pandemic.
<strong>Tailor-Made: Empowering SARS-CoV-2 Researchers Worldwide</strong>
Tailor-Made: Empowering SARS-CoV-2 Researchers Worldwide
The Scientist Creative Services Team | May 26, 2020
Arbor Biosciences is offering free SARS-CoV-2 myBaits kits to all researchers.  
Chemyx: Navigating Legal and Regulatory Requirements for Cannabis Research and Product Development in the United States
Chemyx: Navigating Legal and Regulatory Requirements for Cannabis Research and Product Development in the United States
Chemyx Inc. | Dec 4, 2019
Given its legal status as a controlled substance, researchers, producers, and developers still must be aware of a considerable number of regulatory guidelines and practices governing the cannabis industry.
Chemyx: Cannabis Extraction on the Cutting Edge
Chemyx: Cannabis Extraction on the Cutting Edge
Chemyx Inc. | Dec 3, 2019
Tully Stroud, Chief Scientific Officer for Elite Molecular Labs, talks about the growing field of cannabis extraction and refinement. 
How single cell proteomics data can drive CAR-T<sub>reg</sub>-based therapies&mdash;an interview with Leonardo Ferreira
How single cell proteomics data can drive CAR-Treg-based therapies—an interview with Leonardo Ferreira
IsoPlexis | Oct 18, 2019
Leonardo Ferreira, a postdoctoral fellow at the University of California, San Francisco, discusses the application of single cell proteomics data to understanding the function and therapeutic potential of genetically engineered regulatory T cells.
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
IsoPlexis | Oct 7, 2019
Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogeneic CAR-T cells.